Status:

COMPLETED

Augmenting Massed Prolonged Exposure With a Stellate Ganglion Block to Treat PTSD

Lead Sponsor:

The University of Texas Health Science Center at San Antonio

Collaborating Sponsors:

United States Department of Defense

Conditions:

Stress Disorders, Post-Traumatic

Eligibility:

All Genders

18-65 years

Phase:

EARLY_PHASE1

Brief Summary

This is a small, open-label treatment study that tests the potential safety and treatment effectiveness of a stellate ganglion block combined with Massed Prolonged Exposure (PE). Each of the 12 partic...

Detailed Description

Massed PE will be conducted by doctoral-level therapists. Participants will meet with their providers for individual, 90-minute sessions. They will then be asked to complete out-of-session treatment a...

Eligibility Criteria

Inclusion

  • Active duty or retired military service member (age 18- 65 years)
  • PTSD diagnosis as assessed by Clinician-Administered Posttraumatic Stress Scale (CAPS-5)
  • Able to speak and read English (due to standardization of outcome measures)
  • Defense Enrollment Eligibility Reporting System (DEERS)-eligible to receive care at Brooke Army Medical Center for the stellate ganglion block.

Exclusion

  • Classification as high risk for suicide
  • Current serious mental health diagnosis (e.g., bipolar or psychosis)
  • Symptoms of moderate to severe substance (to include alcohol) use within the last 30 days
  • Pregnancy (i.e. positive pregnancy test at screening) or breastfeeding
  • Current anticoagulant use
  • History of bleeding disorder
  • Infection or mass at injection site
  • Myocardial infarction within 6 months of procedure
  • Pathologic bradycardia or irregularities of heart rate or rhythm;
  • Symptomatic hypotension
  • Phrenic or laryngeal nerve palsy
  • History of glaucoma
  • Uncontrolled seizure disorder
  • History of allergy to local anesthetics

Key Trial Info

Start Date :

October 5 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 3 2021

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT04302181

Start Date

October 5 2020

End Date

December 3 2021

Last Update

September 9 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Brooke Army Medical Center

Fort Sam Houston, Texas, United States, 78234

2

University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States, 78229

Augmenting Massed Prolonged Exposure With a Stellate Ganglion Block to Treat PTSD | DecenTrialz